WILLIAM BENITZ, MD
Medical Practice at Welch Rd, Palo Alto, CA
License number
California G39571
Category
Medical Practice
Type
Neonatal-Perinatal Medicine
Address
Address
725 Welch Rd, Palo Alto, CA 94304
Phone
(650) 498-7103
Organization information
See more information about WILLIAM BENITZ at bizstanding.comNeonatology Administration Office - William Benitz MD
750 Welch Rd STE 315, Palo Alto, CA 94304
Categories:
Pediatrics Physicians & Surgeons
Site:
Phone:
(650) 723-5711 (Phone)
William Benitz MD
725 Welch Rd, Palo Alto, CA 94304
Industry:
Pediatrician
Phone:
(650) 497-8800 (Phone)
William Edwin Benitz
Professional information
William Edwin Benitz, Palo Alto CA
Specialties:
Pediatrics, Neonatal-Perinatal Medicine, Pediatric Cardiology
Work:
Neonatal Intensive Care Unit
725 Welch Rd, Palo Alto, CA 94304 Stanford University
750 Welch Rd, Palo Alto, CA 94304 Stanford University
750 Welch Rd, Stanford, CA 94305
725 Welch Rd, Palo Alto, CA 94304 Stanford University
750 Welch Rd, Palo Alto, CA 94304 Stanford University
750 Welch Rd, Stanford, CA 94305
Education:
Stanford University (1978)
Dr. William Benitz, Palo Alto CA - MD (Doctor of Medicine)
Specialties:
Neonatal Medicine
Address:
Stanford University Medical Center NEO
750 Welch Rd, Palo Alto 94304
(650) 723-5711 (Phone)
750 Welch Rd, Palo Alto 94304
(650) 723-5711 (Phone)
Certifications:
Pediatrics, 1983, Perinatal Medicine & Neonatal Medicine, 2000
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Stanford University Medical Center NEO
750 Welch Rd, Palo Alto 94304
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
750 Welch Rd, Palo Alto 94304
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
Stanford University School Of Medicine
Graduated: 1978
Stanford University Hospital
Graduated: 1979
Graduated: 1982
Stanford University School Med
Graduated: 1985
Stanford University School Of Medicine
Graduated: 1978
Stanford University Hospital
Graduated: 1979
Graduated: 1982
Stanford University School Med
Graduated: 1985
William E Benitz, Palo Alto CA
Specialties:
Pediatrician
Address:
725 Welch Rd, Palo Alto, CA 94304
750 Welch Rd, Palo Alto, CA 94304
750 Welch Rd, Palo Alto, CA 94304
Education:
Stanford University, School of Medicine - Doctor of Medicine
Stanford Hospital & Clinics - Fellowship - Neonatology
Stanford Hospital & Clinics - Residency - Pediatrics
Stanford Hospital & Clinics - Fellowship - Neonatology
Stanford Hospital & Clinics - Residency - Pediatrics
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Neonatal-Perinatal Medicine (Pediatrics)
Rapid Assay For Infection In Neonates
US Patent:
6077665, Jun 20, 2000
Filed:
Apr 8, 1997
Appl. No.:
8/833677
Inventors:
Erica E. Weirich - Redwood City CA
Ronald L. Rabin - Rockville MD
Yvonne Maldonado - Redwood City CA
William E. Benitz - Palo Alto CA
Leonore A. Herzenberg - Stanford CA
Leonard A. Herzenberg - Stanford CA
Ronald L. Rabin - Rockville MD
Yvonne Maldonado - Redwood City CA
William E. Benitz - Palo Alto CA
Leonore A. Herzenberg - Stanford CA
Leonard A. Herzenberg - Stanford CA
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
C12Q 168, G01N 3353
US Classification:
435 6
Abstract:
A rapid assay for infection in immunodeficient patients such as neonates or immunocompromised patients (e. g. HIV or transplant patients) allows diagnosis at initial evaluation, such that antibiotic treatment and confinement to an intensive care unit can be avoided for uninfected patients. The assay can be used for detecting bacterial, viral, or fungal colonization of the blood stream, cerebrospinal fluid (CSF), or urinary tract. The method is particularly useful for sepsis diagnosis. Polymorphonuclear leukocyte (PMN, neutrophil) CD11b (Mac-1, CR3) levels are measured by flow cytometry or laser scanning microscopy in low volume (0. 1 ml) whole blood samples. A dual-laser FACS identifies neutrophils by FITC-conjugated anti-CD15 fluorescent antibodies, and identifies surface neutrophil CD11b marked with PE-conjugated anti-CD11b antibodies. Spontaneous upregulation of CD11b is prevented by handling samples at 4. degree. C. or adding a stabilizing compound such as anti-CD14 antibody or adenosine to the samples.
Smooth Muscle Cell Growth Inhibitor
US Patent:
4945086, Jul 31, 1990
Filed:
May 3, 1988
Appl. No.:
7/189622
Inventors:
William E. Benitz - Palo Alto CA
Merton Bernfield - Palo Alto CA
Merton Bernfield - Palo Alto CA
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Stanford CA
International Classification:
C08B 3710
US Classification:
514 56
Abstract:
An epithelium-derived inhibitor of the growth of smooth muscle cells is disclosed along with methods for purifying this substance. As initially isolated, the inhibitor comprises a heparan sulfate proteoglycan having a buoyant density of less than 1. 4 g/ml which releases a glycosaminoglycan chain having a molecular weight of about 55,000 to 75,000 on protease cleavage. Growth inhibiting activity is found in the glycosaminoglycan chain and in glycosaminoglycan fragments derived therefrom. Use of a dialyzable detergent in purification steps greatly aids in the handling and purification of the inhibitor. The inhibitor can be used in a variety of techniques for inhibiting the growth of smooth muscle cells, both in vivo and in vitro.